{"filings":[{"id":111328,"accession_number":"0001213900-26-014722","cik":1960262,"company_name":"LUDWIG ENTERPRISES, INC.","ticker":"LUDG","form_type":"8-K","filed_at":"2026-02-11T23:59:59+00:00","items":["1.01","2.03","3.02","9.01"],"status":"ready","headline":"Ludwig Enterprises closes $200K convertible note and warrant placement with Alumni Capital LP","event_type":"debt","confidence":"high","bullets":["Issued $250K convertible promissory note to Alumni Capital LP; maturity May 4, 2026; net proceeds $200K after original issue discount.","Note convertible at 70% of lowest 20-day VWAP before conversion; warrant for up to 4,166,667 shares at $0.06 per share.","Securities sold under Section 4(a)(2) and Regulation D; unregistered; no commissions paid.","Conversion price set at deep discount to market; terms imply significant dilution upon conversion or warrant exercise.","Proceeds likely used for general working capital; short maturity indicates urgent financing need."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":127931,"accession_number":"0001213900-25-094718","cik":1960262,"company_name":"LUDWIG ENTERPRISES, INC.","ticker":"LUDG","form_type":"8-K","filed_at":"2025-10-01T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Ludwig Enterprises appoints Jose Antonio Reyes as Interim CEO effective October 1, 2025","event_type":"leadership","confidence":"high","bullets":["Jose Antonio Reyes, who served as CEO from Aug 2024 to Apr 2025, returns as Interim CEO.","He continues as Senior Head of Global Business Development; no compensatory agreement yet.","Reyes previously served as COO from Feb 2023 to Aug 2024; over 30 years leadership experience.","No arrangements or understandings with any other person regarding his appointment.","No family relationships with other directors/officers, no material interest in transactions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":144711,"accession_number":"0001213900-25-085512","cik":1960262,"company_name":"LUDWIG ENTERPRISES, INC.","ticker":"LUDG","form_type":"8-K","filed_at":"2025-09-08T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Ludwig Enterprises appoints Corain McGinn as Independent Director","event_type":"leadership","confidence":"high","bullets":["Corain McGinn appointed as Independent Director effective September 5, 2025.","McGinn, age 56, has executive experience at AMD, Microsoft, Merck, Novartis, and Hitachi.","He fills vacancies on the Board; compensation consistent with non-employee directors.","Board anticipates naming McGinn to committees; amendment to follow."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":144710,"accession_number":"0001213900-25-069395","cik":1960262,"company_name":"LUDWIG ENTERPRISES, INC.","ticker":"LUDG","form_type":"8-K","filed_at":"2025-07-30T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"CEO Charles T. Todd Jr. resigns effective August 23, 2025; no replacement named yet","event_type":"leadership","confidence":"high","bullets":["Charles T. Todd Jr. resigned as CEO of Ludwig Enterprises, effective August 23, 2025.","Resignation not due to any disagreement with the Company's operations, policies, or practices.","30-day notice period intended to allow fluid transition and time to appoint a suitable replacement.","No successor has been named as of the filing date."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":163112,"accession_number":"0001213900-25-057684","cik":1960262,"company_name":"LUDWIG ENTERPRISES, INC.","ticker":"LUDG","form_type":"8-K","filed_at":"2025-06-25T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Ludwig Enterprises appoints Garth Lees-Rolfe as independent director","event_type":"leadership","confidence":"high","bullets":["Garth Lees-Rolfe appointed independent director effective June 23, 2025.","Over 19 years of finance/accounting experience; currently CFO of ABLi Therapeutics.","Previously CFO of Inhibikase Therapeutics (NASDAQ: IKT) and VP Finance at F-Star (NASDAQ: FSTX).","Spent 16 years at Ernst & Young, most recently as Senior Manager; holds CPA and Chartered Accountant licenses.","No family relationships with existing directors or executive officers."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":163111,"accession_number":"0001213900-25-052068","cik":1960262,"company_name":"LUDWIG ENTERPRISES, INC.","ticker":"LUDG","form_type":"8-K","filed_at":"2025-06-06T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Director Marvin S. Hausman resigns from board, remains Chief Scientific Officer","event_type":"leadership","confidence":"high","bullets":["Dr. Marvin S. Hausman resigned from the Board of Directors on June 5, 2025.","He will continue as Chief Scientific Officer, a position he retains.","Resignation is not due to any disagreement with the Company or management."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":163110,"accession_number":"0001213900-25-048524","cik":1960262,"company_name":"LUDWIG ENTERPRISES, INC.","ticker":"LUDG","form_type":"8-K","filed_at":"2025-05-29T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Ludwig Enterprises publishes ASCO abstract on non-invasive breast cancer mRNA test","event_type":"other_material","confidence":"high","bullets":["Abstract details mRNA signal from buccal cells combined with machine learning for breast cancer screening.","Study analyzed 48 mRNA cytokine biomarkers from non-invasive cheek swabs across 40 U.S. clinical centers.","Top biomarker system achieved F1-score of 0.9, precision 0.892, recall 0.913 (AUC 0.897).","Second system achieved F1-score of 0.892, precision 0.888, recall 0.902 (AUC 0.849).","Research presented at ASCO 2025 Annual Meeting; previously under embargo."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}